{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:45:45Z","timestamp":1792788345876,"version":"4.5.0"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T00:00:00Z","timestamp":1620086400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Alzheimer Stiftung G\u00f6ttingen"},{"name":"ibiMED","award":["UID\/BIM\/04501\/2020"],"award-info":[{"award-number":["UID\/BIM\/04501\/2020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Alzheimer\u2019s disease (AD) is a neurodegenerative disorder associated with extracellular amyloid-\u03b2 peptide deposition and progressive neuron loss. Strong evidence supports that neuroinflammatory changes such as the activation of astrocytes and microglia cells are important in the disease process. Glycoprotein nonmetastatic melanoma protein B (GPNMB) is a transmembrane glycoprotein that has recently been associated with an emerging role in neuroinflammation, which has been reported to be increased in post-mortem brain samples from AD and Parkinson\u2019s disease patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The present study describes the partial \u201cfit for purpose\u201d validation of a commercially available immunoassay for the determination of GPNMB levels in the cerebrospinal fluid (CSF). We further assessed the applicability of GPNMB as a potential biomarker for AD in two different cohorts that were defined by biomarker-supported clinical diagnosis or by neuroimaging with amyloid positron emission tomography, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results indicated that CSF GPNMB levels could not distinguish between AD or controls with other neurological diseases but correlated with other parameters such as aging and CSF pTau levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The findings of this study do not support GPNMB in CSF as a valuable neurochemical diagnostic biomarker of AD but warrant further studies employing healthy control individuals.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13195-021-00828-1","type":"journal-article","created":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T15:49:46Z","timestamp":1620143386000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Evaluation of cerebrospinal fluid glycoprotein NMB (GPNMB) as a potential biomarker for Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"13","author":[{"given":"Freyja","family":"Aichholzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Wolfgang","family":"Klafki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Ogorek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Vogelgsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens","family":"Wiltfang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Scherbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Weggen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4115-0334","authenticated-orcid":false,"given":"Oliver","family":"Wirths","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,5,4]]},"reference":[{"issue":"16","key":"828_CR1","first-page":"391","volume":"2020","author":"Alzheimer's Association","year":"2020","unstructured":"Alzheimer's Association. Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2020;2020(16):391\u2013460.","journal-title":"Alzheimers Dement"},{"issue":"4","key":"828_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJMra0909142","volume":"362","author":"HW Querfurth","year":"2010","unstructured":"Querfurth HW, LaFerla FM. Alzheimer\u2019s disease. New Engl J Med. 2010;362(4):329\u201344. https:\/\/doi.org\/10.1056\/NEJMra0909142.","journal-title":"New Engl J Med"},{"issue":"1","key":"828_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00401-014-1347-2","volume":"129","author":"HS Nhan","year":"2015","unstructured":"Nhan HS, Chiang K, Koo EH. The multifaceted nature of amyloid precursor protein and its proteolytic fragments: friends and foes. Acta Neuropathol. 2015;129(1):1\u201319. https:\/\/doi.org\/10.1007\/s00401-014-1347-2.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"828_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s00401-014-1371-2","volume":"129","author":"RM Nisbet","year":"2015","unstructured":"Nisbet RM, Polanco JC, Ittner LM, Gotz J. Tau aggregation and its interplay with amyloid-beta. Acta Neuropathol. 2015;129(2):207\u201320. https:\/\/doi.org\/10.1007\/s00401-014-1371-2.","journal-title":"Acta Neuropathol"},{"issue":"6","key":"828_CR5","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1007\/s00401-018-1932-x","volume":"136","author":"JL Molinuevo","year":"2018","unstructured":"Molinuevo JL, Ayton S, Batrla R, Bednar MM, Bittner T, Cummings J, Fagan AM, Hampel H, Mielke MM, Mikulskis A, O\u2019Bryant S, Scheltens P, Sevigny J, Shaw LM, Soares HD, Tong G, Trojanowski JQ, Zetterberg H, Blennow K. Current state of Alzheimer\u2019s fluid biomarkers. Acta Neuropathol. 2018;136(6):821\u201353. https:\/\/doi.org\/10.1007\/s00401-018-1932-x.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"828_CR6","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/S1474-4422(16)00070-3","volume":"15","author":"B Olsson","year":"2016","unstructured":"Olsson B, Lautner R, Andreasson U, \u00d6hrfelt A, Portelius E, Bjerke M, H\u00f6ltt\u00e4 M, Ros\u00e9n C, Olsson C, Strobel G, Wu E, Dakin K, Petzold M, Blennow K, Zetterberg H. CSF and blood biomarkers for the diagnosis of Alzheimer\u2019s disease: a systematic review and meta-analysis. Lancet Neurol. 2016;15(7):673\u201384. https:\/\/doi.org\/10.1016\/S1474-4422(16)00070-3.","journal-title":"Lancet Neurol"},{"key":"828_CR7","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cca.2016.05.014","volume":"467","author":"J Kuhlmann","year":"2017","unstructured":"Kuhlmann J, Andreasson U, Pannee J, Bjerke M, Portelius E, Leinenbach A, Bittner T, Korecka M, Jenkins RG, Vanderstichele H, Stoops E, Lewczuk P, Shaw LM, Zegers I, Schimmel H, Zetterberg H, Blennow K. CSF A\u03b21\u201342 \u2013 an excellent but complicated Alzheimer\u2019s biomarker \u2013 a route to standardisation. Clin Chim Acta. 2017;467:27\u201333. https:\/\/doi.org\/10.1016\/j.cca.2016.05.014.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"828_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1080\/15622975.2017.1375556","volume":"19","author":"P Lewczuk","year":"2018","unstructured":"Lewczuk P, Riederer P, O\u2019Bryant SE, Verbeek MM, Dubois B, Visser PJ, Jellinger KA, Engelborghs S, Ramirez A, Parnetti L, Jack CR Jr, Teunissen CE, Hampel H, Lle\u00f3 A, Jessen F, Glodzik L, de Leon MJ, Fagan AM, Molinuevo JL, Jansen WJ, Winblad B, Shaw LM, Andreasson U, Otto M, Mollenhauer B, Wiltfang J, Turner MR, Zerr I, Handels R, Thompson AG, Johansson G, Ermann N, Trojanowski JQ, Karaca I, Wagner H, Oeckl P, van Waalwijk van Doorn L, Bjerke M, Kapogiannis D, Kuiperij HB, Farotti L, Li Y, Gordon BA, Epelbaum S, Vos SJB, Klijn CJM, van Nostrand WE, Minguillon C, Schmitz M, Gallo C, Lopez Mato A, Thibaut F, Lista S, Alcolea D, Zetterberg H, Blennow K, Kornhuber J, on Behalf of the Members of the WFSBP Task Force Working on this Topic: Peter Riederer, Carla Gallo, Dimitrios Kapogiannis, Andrea Lopez Mato, Florence Thibaut. Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: an update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry. World J Biol Psychiatry. 2018;19(4):244\u2013328. https:\/\/doi.org\/10.1080\/15622975.2017.1375556.","journal-title":"World J Biol Psychiatry"},{"issue":"10","key":"828_CR9","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1001\/jamaneurol.2014.1358","volume":"71","author":"S Palmqvist","year":"2014","unstructured":"Palmqvist S, Zetterberg H, Blennow K, Vestberg S, Andreasson U, Brooks DJ, Owenius R, H\u00e4gerstr\u00f6m D, Wollmer P, Minthon L, Hansson O. Accuracy of brain amyloid detection in clinical practice using cerebrospinal fluid \u03b2-amyloid 42: a cross-validation study against amyloid positron emission tomography. JAMA Neurol. 2014;71(10):1282\u20139. https:\/\/doi.org\/10.1001\/jamaneurol.2014.1358.","journal-title":"JAMA Neurol"},{"issue":"12","key":"828_CR10","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1001\/jamaneurol.2017.2814","volume":"74","author":"S Janelidze","year":"2017","unstructured":"Janelidze S, Pannee J, Mikulskis A, Chiao P, Zetterberg H, Blennow K, Hansson O. Concordance between different amyloid immunoassays and visual amyloid positron emission tomographic assessment. JAMA Neurol. 2017;74(12):1492\u2013501. https:\/\/doi.org\/10.1001\/jamaneurol.2017.2814.","journal-title":"JAMA Neurol"},{"issue":"11","key":"828_CR11","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Seibyl J, Stomrud E, Zetterberg H, Trojanowski JQ, Bittner T, Lifke V, Corradini V, Eichenlaub U, Batrla R, Buck K, Zink K, Rabe C, Blennow K, Shaw LM, for the Swedish BioFINDER study group, Alzheimer's Disease Neuroimaging Initiative. CSF biomarkers of Alzheimer's disease concord with amyloid-\u03b2 PET and predict clinical progression: a study of fully automated immunoassays in BioFINDER and ADNI cohorts. Alzheimers Dement. 2018;14(11):1470\u201381. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.010.","journal-title":"Alzheimers Dement"},{"issue":"6","key":"828_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.cell.2010.02.016","volume":"140","author":"CK Glass","year":"2010","unstructured":"Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. Mechanisms underlying inflammation in neurodegeneration. Cell. 2010;140(6):918\u201334. https:\/\/doi.org\/10.1016\/j.cell.2010.02.016.","journal-title":"Cell"},{"issue":"4","key":"828_CR13","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka MT, Carson MJ, Khoury JE, Landreth GE, Brosseron F, Feinstein DL, Jacobs AH, Wyss-Coray T, Vitorica J, Ransohoff RM, Herrup K, Frautschy SA, Finsen B, Brown GC, Verkhratsky A, Yamanaka K, Koistinaho J, Latz E, Halle A, Petzold GC, Town T, Morgan D, Shinohara ML, Perry VH, Holmes C, Bazan NG, Brooks DJ, Hunot S, Joseph B, Deigendesch N, Garaschuk O, Boddeke E, Dinarello CA, Breitner JC, Cole GM, Golenbock DT, Kummer MP. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 2015;14(4):388\u2013405. https:\/\/doi.org\/10.1016\/S1474-4422(15)70016-5.","journal-title":"Lancet Neurol"},{"issue":"2","key":"828_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1056\/NEJMoa1211103","volume":"368","author":"T Jonsson","year":"2013","unstructured":"Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U, Kong A, Stefansson K. Variant of TREM2 associated with the risk of Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):107\u201316. https:\/\/doi.org\/10.1056\/NEJMoa1211103.","journal-title":"N Engl J Med"},{"issue":"1","key":"828_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.biopsych.2014.05.006","volume":"77","author":"CM Karch","year":"2015","unstructured":"Karch CM, Goate AM. Alzheimer\u2019s disease risk genes and mechanisms of disease pathogenesis. Biol Psychiatry. 2015;77(1):43\u201351. https:\/\/doi.org\/10.1016\/j.biopsych.2014.05.006.","journal-title":"Biol Psychiatry"},{"issue":"2","key":"828_CR16","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1056\/NEJMoa1211851","volume":"368","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JS, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert JC, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J, Alzheimer Genetic Analysis Group. TREM2 variants in Alzheimer\u2019s disease. N Engl J Med. 2013;368(2):117\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1211851.","journal-title":"N Engl J Med"},{"issue":"11","key":"828_CR17","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1212\/WNL.56.11.1552","volume":"56","author":"BMJ Paloneva","year":"2001","unstructured":"Paloneva BMJ, Autti T, Raininko R, Partanen J, Salonen O, Puranen M, Hakola P, Haltia M. CNS manifestations of Nasu\u2013Hakola disease: a frontal dementia with bone cysts. Neurology. 2001;56(11):1552\u20138. https:\/\/doi.org\/10.1212\/WNL.56.11.1552.","journal-title":"Neurology"},{"issue":"4","key":"828_CR18","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1212\/01.wnl.0000216105.11788.0f","volume":"66","author":"MM Bianchin","year":"2006","unstructured":"Bianchin MM, Lima JE, Natel J, Sakamoto AC. The genetic causes of basal ganglia calcification, dementia, and bone cysts: DAP12 and TREM2. Neurology. 2006;66(4):615\u20136. https:\/\/doi.org\/10.1212\/01.wnl.0000216105.11788.0f.","journal-title":"Neurology"},{"issue":"2","key":"828_CR19","doi-asserted-by":"publisher","first-page":"397","DOI":"10.3233\/JAD-150745","volume":"50","author":"R Weissmann","year":"2016","unstructured":"Weissmann R, Huttenrauch M, Kacprowski T, Bouter Y, Pradier L, Bayer TA, Kuss AW, Wirths O. Gene expression profiling in the APP\/PS1KI mouse model of familial Alzheimer\u2019s disease. J Alzheimers Dis. 2016;50(2):397\u2013409. https:\/\/doi.org\/10.3233\/JAD-150745.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"828_CR20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s40478-018-0612-3","volume":"6","author":"M H\u00fcttenrauch","year":"2018","unstructured":"H\u00fcttenrauch M, Ogorek I, Klafki H, Otto M, Stadelmann C, Weggen S, Wiltfang J, Wirths O. Glycoprotein NMB: a novel Alzheimer\u2019s disease associated marker expressed in a subset of activated microglia. Acta Neuropathol Commun. 2018;6(1):108. https:\/\/doi.org\/10.1186\/s40478-018-0612-3.","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"828_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/ijc.2910600111","volume":"60","author":"MAJ Weterman","year":"1995","unstructured":"Weterman MAJ, Ajubi N, van Dinter IMR, Degen WGJ, van Muijen GNP, Ruiter DJ, HPJ B. nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts. Int J Cancer. 1995;60(1):73\u201381. https:\/\/doi.org\/10.1002\/ijc.2910600111.","journal-title":"Int J Cancer"},{"issue":"10","key":"828_CR22","doi-asserted-by":"publisher","first-page":"6557","DOI":"10.4049\/jimmunol.178.10.6557","volume":"178","author":"VM Ripoll","year":"2007","unstructured":"Ripoll VM, Irvine KM, Ravasi T, Sweet MJ, Hume DA. Gpnmb is induced in macrophages by IFN-\u03b3 and lipopolysaccharide and acts as a feedback regulator of proinflammatory responses. J Immunol. 2007;178(10):6557\u201366. https:\/\/doi.org\/10.4049\/jimmunol.178.10.6557.","journal-title":"J Immunol"},{"issue":"2","key":"828_CR23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/brb3.39","volume":"2","author":"J-J Huang","year":"2012","unstructured":"Huang J-J, Ma W-J, Yokoyama S. Expression and immunolocalization of Gpnmb, a glioma-associated glycoprotein, in normal and inflamed central nervous systems of adult rats. Brain Behav. 2012;2(2):85\u201396. https:\/\/doi.org\/10.1002\/brb3.39.","journal-title":"Brain Behav"},{"key":"828_CR24","doi-asserted-by":"publisher","first-page":"120","DOI":"10.5582\/irdr.2019.01049","volume":"8","author":"S J-i","year":"2019","unstructured":"J-i S, Kino Y, Yanaizu M, Ishida T, Saito Y. Microglia express GPNMB in the brains of Alzheimer\u2019s disease and Nasu-Hakola disease. Intractable Rare Dis Res. 2019;8:120\u20138.","journal-title":"Intractable Rare Dis Res"},{"issue":"5","key":"828_CR25","doi-asserted-by":"publisher","first-page":"466","DOI":"10.15252\/emmm.201506123","volume":"8","author":"M Su\u00e1rez-Calvet","year":"2016","unstructured":"Su\u00e1rez-Calvet M, Kleinberger G, Araque Caballero M\u00c1, Brendel M, Rominger A, Alcolea D, Fortea J, Lle\u00f3 A, Blesa R, Gispert JD, S\u00e1nchez-Valle R, Antonell A, Rami L, Molinuevo JL, Brosseron F, Trasch\u00fctz A, Heneka MT, Struyfs H, Engelborghs S, Sleegers K, van Broeckhoven C, Zetterberg H, Nellg\u00e5rd B, Blennow K, Crispin A, Ewers M, Haass C. sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer\u2019s disease and associate with neuronal injury markers. EMBO Mol Med. 2016;8(5):466\u201376. https:\/\/doi.org\/10.15252\/emmm.201506123.","journal-title":"EMBO Mol Med"},{"key":"828_CR26","doi-asserted-by":"publisher","first-page":"243ra286","DOI":"10.1126\/scitranslmed.3009093","volume":"6","author":"G Kleinberger","year":"2014","unstructured":"Kleinberger G, Yamanishi Y, Su\u00e1rez-Calvet M, Czirr E, Lohmann E, Cuyvers E, Struyfs H, Pettkus N, Wenninger-Weinzierl A, Mazaheri F, et al. TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis. Sci Transl Med. 2014;6:243ra286.","journal-title":"Sci Transl Med"},{"issue":"8","key":"828_CR27","doi-asserted-by":"publisher","first-page":"e12093","DOI":"10.1371\/journal.pone.0012093","volume":"5","author":"AAN Rose","year":"2010","unstructured":"Rose AAN, Annis MG, Dong Z, Pepin F, Hallett M, Park M, Siegel PM. ADAM10 releases a soluble form of the GPNMB\/Osteoactivin extracellular domain with Angiogenic properties. Plos One. 2010;5(8):e12093. https:\/\/doi.org\/10.1371\/journal.pone.0012093.","journal-title":"Plos One"},{"issue":"6166","key":"828_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1126\/science.1247005","volume":"343","author":"O Shalem","year":"2014","unstructured":"Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelsen TS, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science. 2014;343(6166):84\u20137. https:\/\/doi.org\/10.1126\/science.1247005.","journal-title":"Science"},{"issue":"8","key":"828_CR29","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nmeth.3047","volume":"11","author":"NE Sanjana","year":"2014","unstructured":"Sanjana NE, Shalem O, Zhang F. Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods. 2014;11(8):783\u20134. https:\/\/doi.org\/10.1038\/nmeth.3047.","journal-title":"Nat Methods"},{"issue":"2","key":"828_CR30","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s00401-018-1929-5","volume":"137","author":"S Walter","year":"2019","unstructured":"Walter S, Jumpertz T, H\u00fcttenrauch M, Ogorek I, Gerber H, Storck SE, Zampar S, Dimitrov M, Lehmann S, Lepka K, Berndt C, Wiltfang J, Becker-Pauly C, Beher D, Pietrzik CU, Fraering PC, Wirths O, Weggen S. The metalloprotease ADAMTS4 generates N-truncated A\u03b24\u2013x species and marks oligodendrocytes as a source of amyloidogenic peptides in Alzheimer\u2019s disease. Acta Neuropathol. 2019;137(2):239\u201357. https:\/\/doi.org\/10.1007\/s00401-018-1929-5.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"828_CR31","doi-asserted-by":"publisher","first-page":"691","DOI":"10.3233\/JAD-160398","volume":"54","author":"HW Klafki","year":"2016","unstructured":"Klafki HW, Hafermann H, Bauer C, Haussmann U, Kraus I, Schuchhardt J, Muck S, Scherbaum N, Wiltfang J. Validation of a commercial chemiluminescence immunoassay for the simultaneous measurement of three different amyloid-beta peptides in human cerebrospinal fluid and application to a clinical cohort. J Alzheimers Dis. 2016;54(2):691\u2013705. https:\/\/doi.org\/10.3233\/JAD-160398.","journal-title":"J Alzheimers Dis"},{"key":"828_CR32","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.cca.2019.02.005","volume":"492","author":"C Bouter","year":"2019","unstructured":"Bouter C, Vogelgsang J, Wiltfang J. Comparison between amyloid-PET and CSF amyloid-\u03b2 biomarkers in a clinical cohort with memory deficits. Clin Chim Acta. 2019;492:62\u20138. https:\/\/doi.org\/10.1016\/j.cca.2019.02.005.","journal-title":"Clin Chim Acta"},{"issue":"2","key":"828_CR33","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.jneumeth.2009.06.033","volume":"183","author":"O Calero","year":"2009","unstructured":"Calero O, Hortig\u00fcela R, Bullido MJ, Calero M. Apolipoprotein E genotyping method by real time PCR, a fast and cost-effective alternative to the TaqMan\u00ae and FRET assays. J Neurosci Methods. 2009;183(2):238\u201340. https:\/\/doi.org\/10.1016\/j.jneumeth.2009.06.033.","journal-title":"J Neurosci Methods"},{"issue":"1","key":"828_CR34","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3(1):32\u20135. https:\/\/doi.org\/10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3.","journal-title":"Cancer"},{"issue":"7","key":"828_CR35","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1093\/aje\/kwj063","volume":"163","author":"NJ Perkins","year":"2006","unstructured":"Perkins NJ, Schisterman EF. The inconsistency of \u201coptimal\u201d cutpoints obtained using two criteria based on the receiver operating characteristic curve. Am J Epidemiol. 2006;163(7):670\u20135. https:\/\/doi.org\/10.1093\/aje\/kwj063.","journal-title":"Am J Epidemiol"},{"key":"828_CR36","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio C, Wolfs L, Fattorelli N, Thrupp N, Voytyuk I, Schmidt I, Mancuso R, Chen W-T, Woodbury ME, Srivastava G, et al. The major risk factors for Alzheimers disease: age, sex, and genes modulate the microglia response to Abeta plaques. Cell Rep. 2019;27:1293\u20131306.e1296.","journal-title":"Cell Rep"},{"issue":"1","key":"828_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.immuni.2018.11.004","volume":"50","author":"TR Hammond","year":"2019","unstructured":"Hammond TR, Dufort C, Dissing-Olesen L, Giera S, Young A, Wysoker A, Walker AJ, Gergits F, Segel M, Nemesh J, Marsh SE, Saunders A, Macosko E, Ginhoux F, Chen J, Franklin RJM, Piao X, McCarroll SA, Stevens B. Single-cell RNA sequencing of microglia throughout the mouse lifespan and in the injured brain reveals complex cell-state changes. Immunity. 2019;50(1):253\u201371 e256. https:\/\/doi.org\/10.1016\/j.immuni.2018.11.004.","journal-title":"Immunity"},{"key":"828_CR38","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, David E, Baruch K, Lara-Astaiso D, Toth B, et al. A unique microglia type associated with restricting fevelopment of Alzheimer\u2019s disease. Cell. 2017;169:1276\u20131290.e1217.","journal-title":"Cell"},{"key":"828_CR39","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.immuni.2017.08.008","volume":"47","author":"S Krasemann","year":"2017","unstructured":"Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, Beckers L, O\u2019Loughlin E, Xu Y, Fanek Z, et al. The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity. 2017;47:566\u2013581.e569.","journal-title":"Immunity"},{"issue":"4","key":"828_CR40","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12031-019-01411-y","volume":"69","author":"S Zhu","year":"2019","unstructured":"Zhu S, Wuolikainen A, Wu J, \u00d6hman A, Wingsle G, Moritz T, Andersen PM, Forsgren L, Trupp M. Targeted multiple reaction monitoring analysis of CSF identifies UCHL1 and GPNMB as candidate biomarkers for ALS. J Mol Neurosci. 2019;69(4):643\u201357. https:\/\/doi.org\/10.1007\/s12031-019-01411-y.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"828_CR41","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1007\/s00401-019-02093-x","volume":"139","author":"P Oeckl","year":"2020","unstructured":"Oeckl P, Weydt P, Thal DR, Weishaupt JH, Ludolph AC, Otto M. Proteomics in cerebrospinal fluid and spinal cord suggests UCHL1, MAP 2 and GPNMB as biomarkers and underpins importance of transcriptional pathways in amyotrophic lateral sclerosis. Acta Neuropathol. 2020;139(1):119\u201334. https:\/\/doi.org\/10.1007\/s00401-019-02093-x.","journal-title":"Acta Neuropathol"},{"issue":"30","key":"828_CR42","doi-asserted-by":"publisher","first-page":"5743","DOI":"10.1016\/j.febslet.2007.11.036","volume":"581","author":"H Furochi","year":"2007","unstructured":"Furochi H, Tamura S, Mameoka M, Yamada C, Ogawa T, Hirasaka K, Okumura Y, Imagawa T, Oguri S, Ishidoh K, Kishi K, Higashiyama S, Nikawa T. Osteoactivin fragments produced by ectodomain shedding induce MMP-3 expression via ERK pathway in mouse NIH-3T3 fibroblasts. FEBS Lett. 2007;581(30):5743\u201350. https:\/\/doi.org\/10.1016\/j.febslet.2007.11.036.","journal-title":"FEBS Lett"},{"issue":"5","key":"828_CR43","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1096\/fj.09-151019","volume":"24","author":"T Hoashi","year":"2010","unstructured":"Hoashi T, Sato S, Yamaguchi Y, Passeron T, Tamaki K, Hearing VJ. Glycoprotein nonmetastatic melanoma protein b, a melanocytic cell marker, is a melanosome-specific and proteolytically released protein. FASEB J. 2010;24(5):1616\u201329. https:\/\/doi.org\/10.1096\/fj.09-151019.","journal-title":"FASEB J"},{"issue":"12","key":"828_CR44","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1271\/bbb.120515","volume":"76","author":"K Utsunomiya","year":"2012","unstructured":"Utsunomiya K, Owaki K, Okumura Y, Yano M, Oto T, Suzuki E, Tamura S, Abe T, Kohno S, Ohno A, et al. An intracellular fragment of osteoactivin formed by ectodomain shedding translocated to the nucleoplasm and bound to RNA binding proteins. Biosci Biotechnol Biochem. 2012;76(12):2225\u20139. https:\/\/doi.org\/10.1271\/bbb.120515.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"3","key":"828_CR45","doi-asserted-by":"publisher","first-page":"e0120194","DOI":"10.1371\/journal.pone.0120194","volume":"10","author":"H Zigdon","year":"2015","unstructured":"Zigdon H, Savidor A, Levin Y, Meshcheriakova A, Schiffmann R, Futerman AH. Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease. Plos One. 2015;10(3):e0120194. https:\/\/doi.org\/10.1371\/journal.pone.0120194.","journal-title":"Plos One"},{"issue":"9","key":"828_CR46","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/2211-5463.12078","volume":"6","author":"G Kramer","year":"2016","unstructured":"Kramer G, Wegdam W, Donker-Koopman W, Ottenhoff R, Gaspar P, Verhoek M, Nelson J, Gabriel T, Kallemeijn W, Boot RG, Laman JD, Vissers JPC, Cox T, Pavlova E, Moran MT, Aerts JM, Eijk M. Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models. FEBS Open Bio. 2016;6(9):902\u201313. https:\/\/doi.org\/10.1002\/2211-5463.12078.","journal-title":"FEBS Open Bio"},{"key":"828_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nbd.2018.08.013","volume":"120","author":"EB Moloney","year":"2018","unstructured":"Moloney EB, Moskites A, Ferrari EJ, Isacson O, Hallett PJ. The glycoprotein GPNMB is selectively elevated in the substantia nigra of Parkinson\u2019s disease patients and increases after lysosomal stress. Neurobiol Dis. 2018;120:1\u201311. https:\/\/doi.org\/10.1016\/j.nbd.2018.08.013.","journal-title":"Neurobiol Dis"},{"issue":"7","key":"828_CR48","doi-asserted-by":"publisher","first-page":"2920","DOI":"10.1007\/s12035-020-01921-6","volume":"57","author":"KM Budge","year":"2020","unstructured":"Budge KM, Neal ML, Richardson JR, Safadi FF. Transgenic overexpression of GPNMB protects against MPTP-induced neurodegeneration. Mol Neurobiol. 2020;57(7):2920\u201333. https:\/\/doi.org\/10.1007\/s12035-020-01921-6.","journal-title":"Mol Neurobiol"},{"issue":"1","key":"828_CR49","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s13024-020-00384-6","volume":"15","author":"H Wang","year":"2020","unstructured":"Wang H, Dey KK, Chen P-C, Li Y, Niu M, Cho J-H, Wang X, Bai B, Jiao Y, Chepyala SR, Haroutunian V, Zhang B, Beach TG, Peng J. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer\u2019s disease. Mol Neurodegener. 2020;15(1):43. https:\/\/doi.org\/10.1186\/s13024-020-00384-6.","journal-title":"Mol Neurodegener"},{"issue":"6","key":"828_CR50","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2019.12.015","volume":"105","author":"B Bai","year":"2020","unstructured":"Bai B, Wang X, Li Y, Chen P-C, Yu K, Dey KK, Yarbro JM, Han X, Lutz BM, Rao S, Jiao Y, Sifford JM, Han J, Wang M, Tan H, Shaw TI, Cho JH, Zhou S, Wang H, Niu M, Mancieri A, Messler KA, Sun X, Wu Z, Pagala V, High AA, Bi W, Zhang H, Chi H, Haroutunian V, Zhang B, Beach TG, Yu G, Peng J. Deep multilayer brain proteomics identifies molecular networks in Alzheimer\u2019s disease progression. Neuron. 2020;105(6):975\u201391. https:\/\/doi.org\/10.1016\/j.neuron.2019.12.015.","journal-title":"Neuron"},{"issue":"3-4","key":"828_CR51","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1159\/000492151","volume":"46","author":"Y Kim","year":"2018","unstructured":"Kim Y, Rosenberg P, Oh E. A review of diagnostic impact of amyloid positron emission tomography imaging in clinical practice. Dement Geriatr Cogn Disord. 2018;46(3-4):154\u201367. https:\/\/doi.org\/10.1159\/000492151.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"8","key":"828_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1016\/j.jalz.2015.02.004","volume":"11","author":"O Sabri","year":"2015","unstructured":"Sabri O, Sabbagh MN, Seibyl J, Barthel H, Akatsu H, Ouchi Y, Senda K, Murayama S, Ishii K, Takao M, Beach TG, Rowe CC, Leverenz JB, Ghetti B, Ironside JW, Catafau AM, Stephens AW, Mueller A, Koglin N, Hoffmann A, Roth K, Reininger C, Schulz-Schaeffer WJ, Florbetaben Phase 3 Study Group. Florbetaben PET imaging to detect amyloid beta plaques in Alzheimer\u2019s disease: phase 3 study. Alzheimers Dement. 2015;11(8):964\u201374. https:\/\/doi.org\/10.1016\/j.jalz.2015.02.004.","journal-title":"Alzheimers Dement"},{"key":"828_CR53","doi-asserted-by":"publisher","unstructured":"Holtzman DM, Herz J, Bu G. Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med. 2012;2(3). https:\/\/doi.org\/10.1101\/cshperspect.a006312.","DOI":"10.1101\/cshperspect.a006312"},{"key":"828_CR54","doi-asserted-by":"publisher","first-page":"e101997","DOI":"10.15252\/embj.2019101997","volume":"38","author":"V Stratoulias","year":"2019","unstructured":"Stratoulias V, Venero JL, Tremblay M-\u00c8, Joseph B. Microglial subtypes: diversity within the microglial community. EMBO J. 2019;38:e101997.","journal-title":"EMBO J"}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-021-00828-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-021-00828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T13:02:39Z","timestamp":1636635759000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-021-00828-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,4]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["828"],"URL":"https:\/\/doi.org\/10.1186\/s13195-021-00828-1","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,4]]},"assertion":[{"value":"3 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 October 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The paper was amended to add the OA funding note.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The collection and archiving of biological samples and clinical data in strictly pseudonymous form in a local biobank and their use in biomarker research were approved by the ethics committee of the University Medical Center Goettingen (9\/2\/16) and LVR-Hospital Essen (12-5160-BO). Written informed consent was obtained prior to the inclusion in the biobank from all participants or their legal representatives. All procedures involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave consent for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"NS received honoraria for several activities (advisory boards, lectures, manuscripts) from AbbVie, Camurus, Hexal, Janssen-Cilag, MSD, Medice, Mundipharma, Reckitt-Benckiser\/Indivior, and Sanofi-Aventis. During the last 3\u00a0years, he participated in clinical trials financed by the pharmaceutical industry. All other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"94"}}